Given our finding that NOTCH1 promotes BRCA1-deficient tumour growth by activating ATR–CHK1 and inducing EMT, we inhibited the ATR/CHK1 pathway in combination with a low dose of cisplatin to effectively kill TNBC in our mouse model and PDX model55. This evidence concerns the gene ATR and neoplasm.